A new study has found that users of Ozempic or a similar drug had a 40% lower rate of opioid overdose and a 50% lower rate of alcohol intoxication than those without a prescription. Fernanda ...

We're living in the era of Ozempic. For others, however, the accessibility has led to misuse. "We have a little bit of a wild west in who's writing for this medication now, because it is so ...

While plenty of people rave about the weight loss results you can get from drugs like Ozempic, there’s also been a ton of chatter over the fact that these meds are really expensive. These drugs ...

As prices for Ozempic have risen in recent months, many people may be seeking cheaper alternatives for managing diabetes or weight loss. Some doctors, along with the U.S. Food and Drug ...

The sky continues to be the limit for semaglutide, the active ingredient in popular drugs Ozempic and Wegovy. Newly published research is the latest to suggest that semaglutide and other GLP-1 ...

Ozempic (semaglutide) and Wegovy (semaglutide) are prescription drugs that may be used to help with long-term weight loss. But only Wegovy is FDA-approved for this use. Both drugs are approved for ...

Ozempic (semaglutide) and Victoza (liraglutide) are prescription drugs used to treat type 2 diabetes and reduce the risk of cardiovascular problems. Both drugs come as an injection. Ozempic and ...

A plastic surgeon has gone viral on TikTok for sharing a sobering truth about the weight-loss drug Ozempic. Dr. Jonathan Kaplan, a board-certified plastic surgeon from San Francisco, has amassed 1 ...

Ozempic and related weight loss drugs may help people struggling with addiction, as they've been linked to a 40 percent reduction in opioid overdose and 50 percent lower rate of alcohol ...

Diabetes and weight loss drugs like Mounjaro and Ozempic may also help patients suffering from addiction, according to a new study. In the study, published Thursday in the scientific journal ...

After years of ongoing shortages due to their growing popularity, all doses of both Ozempic and Wegovy are now listed as "available" on the U.S. Food and Drug Administration's drug shortage list.

Among the findings, the report published Monday highlights the impact of Ozempic, other GLP-1 drugs and hormones used in gender-affirming care and lays out sex- and gender-specific risks of stroke.